Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Escape Your Limits & LIFTS

LIFTS Ep 5 - Nautilus, Anytime Fitness & Apple, Centr, Lifetime Fitness & Semaglutide | Latest Fitness News

15 Nov 2023

Description

Welcome back to L.I.F.T.S, bringing you the Latest Industry Fitness Trends and stories hitting the headlines and stirring up some debate.   This week's episode is jam-packed with news as hosts Matthew Januszek, Co-Founder of Escape Fitness and Mo Iqbal, Founder & CEO of Sweatworks, together with special guest, Debra Strougo, fitness industry advisor and founder of Row House, dissect the headlines rocking the fitness world. Every week, our hosts discuss the breaking news, providing their own perspective on the headlines whilst provoking thoughts and conversations, all delivered in a quick-fix, 30-minute podcast. Today's discussion is driven by the following news agenda: The rebranding of Nautilus. Anytime Fitness' collaboration with Apple. HYROX and Centr's partnership. Lifetime Fitness' move to offer member injectable weight loss drug. ====================================================== Subscribe to our YouTube channel and turn on your notifications so you never miss a new video when it's published: https://www.youtube.com/user/EscapeFitness Shop gym equipment: https://escapefitness.com/shop View our full catalog:  https://escapefitness.com/support/catalog https://escapefitness.com/support/catalogue  ====================================================== Facebook: https://www.facebook.com/Escapefitness Instagram: https://www.instagram.com/escapefitness Twitter: https://www.twitter.com/escapefitness LinkedIn: https://www.linkedin.com/company/escapefitness/  

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.